Amidst the ongoing battle against the COVID-19 pandemic, the utilization of antigen tests for mass screening has emerged as a pivotal strategy in pandemic control efforts worldwide. These rapid diagnostic tests offer a valuable tool in identifying infected individuals swiftly and efficiently, thereb

In fact, COVID-19 cases in the United States are more than 90% who have not received any virus tests. The main reason is that nucleic acid detection and antibody detection can not provide fast and accurate COVID-19 detection results in the early stage of virus infection.

Antibodies Rapid Test: the IVDR will replace the existing in vitro diagnostic medical devices Directive. Is your company ready for IVDR, or is there a dangerous gap in your strategy?

Total Antibodies Rapid Test: Omicron may rule the world. Most antibody drugs lose their effect, but small-molecule antiviral drugs have little effect.

With the end of the Christmas and New Year holidays, Omicron infections have shown an "explosive" increase in European and American countries, once again disrupting people's daily lives. However, in the face of this "unprecedented epidemic tsunami", some experts said, "If everyone you know is now infected with the Covid-19 virus.

Rapid antibody detection kit: a necessity in epidemic situation. After that, it can stay in the patient's body for several months, and the virus can spread to all parts of the body and continue to attack the heart and brain.

Since the outbreak of COVID-19, virus nucleic acid detection and antibody detection methods have been widely applied, and to a certain extent, contain the spread of the virus. However, according to the disclosure of the CDC at home and abroad, most virus carriers were not identified in time in the early stage of infection.